fbpx
我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

PLEASE NOTE, WE NEED YOU TO ….
  • Read the important documents for this study
  • If you are interested, look at the dates that this study is being run (cohort visit planners) and  reply to our email (don’t re-register online) to let us know which cohort(s) you are available for
  • We will ring you to check your suitability and provide further information about the study
  • We will make you a screening appointment at NZCR Auckland. You will need to attend at the scheduled time if you wish to take part in the study

Study Information

New Zealand Clinical Research is trialling an investigational drug that may potentially be used for the treatment of obesity and/or insulin resistance (e.g., type 2 diabetes).

Worldwide, obesity and diabetes effect approximately 12-13% of adults. This rate continues to grow every year. The two conditions are closely linked and can lead to other serious consequences, including heart disease.

The investigational drug primarily targets the liver to enhance the breakdown of fat and overall reduce the fat content in the liver.  Over time, this activity may also lead to the breakdown of fat outside the liver as well. These actions improve the sensitivity of the body to insulin, lowering blood sugars, and over time, decreasing the risk of developing diabetes or the severity of diabetes, if already present.

It is an investigational drug because it has not been approved by MedSafe or other drug regulatory authorities.

Clinical trials involve an investigative drug and some study assessments.

This study (2024 AM 15237) is being funded by OrsoBio, Inc. and has been approved by the Health and Disability Ethics Committee.

Study Candidates

  • Male or Female
  • Aged between 18 – 70 years
  • BMI (Body Mass Index) between 30 – 50 kg/m2
  • Have at least one unsuccessful attempt to lose weight from lifestyle changes
  • Not currently taking weight loss medication
  • No change in weight of more than 5 kg within prior 90 daysF
  • Non-smokers or ex-smokers

What is Involved?

  • Study Visits: 9 visits + 2 optional MRI appointments
  • Compensation: up to $4,300 (less tax) + optional $300 (less tax)

Important Documents

Important documents to download and read

Pre-screening Form

Azure Part G

Pre screening for Azure Part G

Personal details

Please provide your name, email and phone number so we can contact you
NZCR Site(Required)
Which site are you located at?

Medical questions

Have you had any covid symptoms in the last 4 weeks or been in isolation?
Have you previously participated in a study with NZCR or any other organisation?
This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for females). Are you currently using 2 forms of contraception?
Have you received blood or plasma in the last 56 days? If yes please provide details
The study does not accept any current smokers. Have you used any nicotine or tobacco containing products in the last 3 months?
Have you received any vaccinations in the last 14 days?
Do you have any History of Diabetes?
Have you had any history of skin diseases such as rash, food allergies, psoriasis or hives?
Any history of abnormal liver or kidney conditions?
Do you have any significant heart disease or heart related conditions/abnormalities? Do you have any family history of heart conditions?
Do you have any history of allergies, asthma, hay fever, food allergies etc that you are aware of?
Any significant history of acid reflux or peptic (stomach) ulcers?
Do you have any history of clinically significant acute systemic infection and/or antibiotic treatment within 28 days?
Have you been sick in the last 30 days?
Have you ever undergone any gastric or intestinal surgery? For example, gastric bypass and gastric sleeve.
Do you have any history of medical conditions relating to:(Required)
If you have none, please select the last option.
Have you taken any prescription, vitamins, supplements, pharmacy medication or over the counter medications in the last 28 days? Please include any Vaccines in the last 3 months
Have you looked at the study dates and are okay to come in those days? Indicate which group/s you are available for. This means having flexibility for more than one group increases your chances of being accepted into a group.
Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?
Pre-screening form policy(Required)
I understand that by submitting this form, NZCR will use the information for pre-screening purposes for this study. This information may be recorded on your profile to allow us to improve our process when screening you for a future study. All information provided is confidential. I also understand that by submitting this form, I will be receiving emails, texts or calls about this study. For more information, please refer to the Privacy Policy.